Works matching DE "CYSTIC fibrosis transmembrane conductance regulator"
Results: 1395
Correction: Ribosomal Stalk Protein Silencing Partially Corrects the ΔF508-CFTR Functional Expression Defect.
- Published in:
- 2016
- By:
- Publication type:
- Correction Notice
Photochemically Activated Notch Signaling Hydrogel Preferentially Differentiates Human Derived Hepatoblasts to Cholangiocytes.
- Published in:
- Advanced Functional Materials, 2021, v. 31, n. 5, p. 1, doi. 10.1002/adfm.202006116
- By:
- Publication type:
- Article
Ethanol and its non-oxidative metabolites profoundly inhibit CFTR function in pancreatic epithelial cells which is prevented by ATP supplementation.
- Published in:
- Pflügers Archiv: European Journal of Physiology, 2014, v. 466, n. 3, p. 549, doi. 10.1007/s00424-013-1333-x
- By:
- Publication type:
- Article
Relative contribution of different transmembrane segments to the CFTR chloride channel pore.
- Published in:
- Pflügers Archiv: European Journal of Physiology, 2014, v. 466, n. 3, p. 477, doi. 10.1007/s00424-013-1317-x
- By:
- Publication type:
- Article
Improved Nutritional Outcomes and Gastrointestinal Symptoms in Adult Cystic Fibrosis Patients Treated with Elexacaftor/Tezacaftor/Ivacaftor.
- Published in:
- Digestive Diseases, 2024, v. 42, n. 4, p. 361, doi. 10.1159/000538606
- By:
- Publication type:
- Article
Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung.
- Published in:
- Nature, 2012, v. 487, n. 7405, p. 109, doi. 10.1038/nature11130
- By:
- Publication type:
- Article
Drug bests cystic-fibrosis mutation.
- Published in:
- Nature, 2012, v. 482, n. 7384, p. 145, doi. 10.1038/482145a
- By:
- Publication type:
- Article
Assessment of Physical Condition in Cystic Fibrosis Patients during 12-month Treatment with Cystic Fibrosis Transmembrane Conductance Regulator Modulators.
- Published in:
- Central European Journal of Paediatrics, 2024, v. 20, n. 1, p. 14, doi. 10.5457/p2005-114.354
- By:
- Publication type:
- Article
FIBROTERAPIA COM MODULADORES DE CFTR PARA PACIENTES COM FIBROSE CÍSTICA-ARTIGO DE REVISÃO.
- Published in:
- Revista Foco (Interdisciplinary Studies Journal), 2024, v. 17, n. 8, p. 1, doi. 10.54751/revistafoco.v17n8-031
- By:
- Publication type:
- Article
IMPLEMENTING THE BRODY SCORING SYSTEM IN THE EVALUATION OF SEVERITY OF PULMONARY CHANGES IN CYSTIC FIBROSIS ON HIGH RESOLUTION COMPUTED TOMOGRAPHY.
- Published in:
- Knowledge: International Journal, 2022, v. 55, n. 4, p. 551
- By:
- Publication type:
- Article
NLC Abstracts.
- Published in:
- European Clinical Respiratory Journal, 2022, v. 9, p. 1, doi. 10.1080/20018525.2022.2058255
- By:
- Publication type:
- Article
Clinical and prognostic importance of chromosomal abnormalities, Y chromosome microdeletions, and CFTR gene mutations in individuals with azoospermia or severe oligospermia.
- Published in:
- Turkish Journal of Medical Sciences, 2014, v. 44, n. 2, p. 347, doi. 10.3906/sag-1301-67
- By:
- Publication type:
- Article
Molecular dynamics simulation study on the structural instability of the most common cystic fibrosis-associated mutant ΔF508-CFTR.
- Published in:
- Biophysics & Physicobiology, 2018, v. 15, n. 1, p. 33, doi. 10.2142/biophysico.15.0_33
- By:
- Publication type:
- Article
Evaluating sequence data quality from the Swift Accel-Amplicon CFTR Panel.
- Published in:
- Scientific Data, 2020, v. 7, n. 1, p. 1, doi. 10.1038/s41597-019-0339-4
- By:
- Publication type:
- Article
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Healthcare Resource Utilization and Associated Costs Among People With Cystic Fibrosis in the US: A Retrospective Claims Analysis.
- Published in:
- Pulmonary Therapy, 2023, v. 9, n. 4, p. 479, doi. 10.1007/s41030-023-00241-z
- By:
- Publication type:
- Article
Comparison of Reporting Quality in National Cystic Fibrosis Patient Registries: Implications for Identifying Use of Novel CFTR Modulators.
- Published in:
- Pulmonary Therapy, 2024, v. 10, n. 4, p. 427, doi. 10.1007/s41030-024-00274-y
- By:
- Publication type:
- Article
Rate of Lung Function Decline in People with Cystic Fibrosis Having a Residual Function Gene Mutation.
- Published in:
- Pulmonary Therapy, 2022, v. 8, n. 4, p. 385, doi. 10.1007/s41030-022-00202-y
- By:
- Publication type:
- Article
Cystic Fibrosis and Sleep Circadian Rhythms.
- Published in:
- Pulmonary Therapy, 2022, v. 8, n. 2, p. 139, doi. 10.1007/s41030-022-00184-x
- By:
- Publication type:
- Article
CFTR Modulator Therapy and Its Impact on Lung Transplantation in Cystic Fibrosis.
- Published in:
- Pulmonary Therapy, 2021, v. 7, n. 2, p. 377, doi. 10.1007/s41030-021-00170-9
- By:
- Publication type:
- Article
Real-World Long-Term Ivacaftor for Cystic Fibrosis in France: Clinical Effectiveness and Healthcare Resource Utilization.
- Published in:
- Pulmonary Therapy, 2021, v. 7, n. 2, p. 455, doi. 10.1007/s41030-021-00158-5
- By:
- Publication type:
- Article
Long-Term Ivacaftor in People Aged 6 Years and Older with Cystic Fibrosis with Ivacaftor-Responsive Mutations.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 303, doi. 10.1007/s41030-020-00129-2
- By:
- Publication type:
- Article
Physiologically Based Pharmacokinetic Modeling of CFTR Modulation in People with Cystic Fibrosis Transitioning from Mono or Dual Regimens to Triple-Combination Elexacaftor/Tezacaftor/Ivacaftor.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 2, p. 275, doi. 10.1007/s41030-020-00124-7
- By:
- Publication type:
- Article
Treatment of Pulmonary Disease of Cystic Fibrosis: A Comprehensive Review.
- Published in:
- Antibiotics (2079-6382), 2021, v. 10, n. 5, p. 486, doi. 10.3390/antibiotics10050486
- By:
- Publication type:
- Article
Etiological involvement of CFTR in apparently unrelated human diseases.
- Published in:
- Molecular & Cellular Oncology, 2019, v. 6, n. 1, p. 1, doi. 10.1080/23723556.2018.1558874
- By:
- Publication type:
- Article
The Expression of Affective Temperaments in Cystic Fibrosis Patients: Psychopathological Associations and Possible Neurobiological Mechanisms.
- Published in:
- Brain Sciences (2076-3425), 2023, v. 13, n. 4, p. 619, doi. 10.3390/brainsci13040619
- By:
- Publication type:
- Article
The Functional Impact of VX-770 on the Cystic Fibrosis Transmembrane Conductance Regulator Is Enduring and Increases the Constitutive Activity of This Channel in Primary Airway Epithelia Generated from Healthy Donors.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 11, p. 1378, doi. 10.3390/biom14111378
- By:
- Publication type:
- Article
Matrix Metalloproteinases in Health and Disease 3.0.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 9, p. 1059, doi. 10.3390/biom14091059
- By:
- Publication type:
- Article
Cystic Fibrosis Bone Disease: The Interplay between CFTR Dysfunction and Chronic Inflammation.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 3, p. 425, doi. 10.3390/biom13030425
- By:
- Publication type:
- Article
The Role of MMPs in the Era of CFTR Modulators: An Additional Target for Cystic Fibrosis Patients?
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 2, p. 350, doi. 10.3390/biom13020350
- By:
- Publication type:
- Article
An Update on CFTR Drug Discovery: Opportunities and Challenges.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 6, p. 792, doi. 10.3390/biom12060792
- By:
- Publication type:
- Article
Exome sequencing for assessing the risk of 453 monogenic disorders in offspring: A study of 832 Chinese couples.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 11, p. 1, doi. 10.1002/ctm2.70074
- By:
- Publication type:
- Article
Heavy metals in cigarette smoke strongly inhibit pancreatic ductal function and promote development of chronic pancreatitis.
- Published in:
- Clinical & Translational Medicine, 2024, v. 14, n. 6, p. 1, doi. 10.1002/ctm2.1733
- By:
- Publication type:
- Article
Stops making sense – For the people?
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 5, p. 1, doi. 10.1002/ctm2.1270
- By:
- Publication type:
- Article
Multimodal analysis of granulocytes, monocytes, and platelets in patients with cystic fibrosis before and after Elexacaftor-Tezacaftor-Ivacaftor treatment.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1180282
- By:
- Publication type:
- Article
The STING/TBK1/IRF3/IFN type I pathway is defective in cystic fibrosis.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1093212
- By:
- Publication type:
- Article
Loss of CFTR function is associated with reduced bitter taste receptor-stimulated nitric oxide innate immune responses in nasal epithelial cells and macrophages.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 01, doi. 10.3389/fimmu.2023.1096242
- By:
- Publication type:
- Article
Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.928300
- By:
- Publication type:
- Article
Teaching molecular phylogenetics through investigating a real-world phylogenetic problem.
- Published in:
- Journal of Biological Education (Taylor & Francis Ltd), 2012, v. 46, n. 2, p. 103, doi. 10.1080/00219266.2011.634018
- By:
- Publication type:
- Article
Direct interaction of a CFTR potentiator and a CFTR corrector with phospholipid bilayers.
- Published in:
- European Biophysics Journal, 2014, v. 43, n. 6/7, p. 341, doi. 10.1007/s00249-014-0956-y
- By:
- Publication type:
- Article
The Distribution and Role of the CFTR Protein in the Intracellular Compartments.
- Published in:
- Membranes, 2021, v. 11, n. 11, p. 804, doi. 10.3390/membranes11110804
- By:
- Publication type:
- Article
Cystic Fibrosis Transmembrane Conductance Regulator Attenuates Oxidative Stress-Induced Injury in Diabetic Retinopathy Rats.
- Published in:
- Current Eye Research, 2023, v. 48, n. 4, p. 416, doi. 10.1080/02713683.2022.2156548
- By:
- Publication type:
- Article
CFTR-Mediated Cl<sup>−</sup> Transport in the Acinar and Duct Cells of Rabbit Lacrimal Gland.
- Published in:
- Current Eye Research, 2012, v. 37, n. 8, p. 671, doi. 10.3109/02713683.2012.675613
- By:
- Publication type:
- Article
A multimodal iPSC platform for cystic fibrosis drug testing.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31854-8
- By:
- Publication type:
- Article
Improvements in Glucose Regulation in Children and Young People with Cystic Fibrosis-Related Diabetes following Initiation of Elexacaftor/Tezacaftor/Ivacaftor.
- Published in:
- Hormone Research in Paediatrics, 2024, v. 97, n. 1, p. 94, doi. 10.1159/000530571
- By:
- Publication type:
- Article
HMGB1: A Possible Crucial Therapeutic Target for COVID-19?
- Published in:
- Hormone Research in Paediatrics, 2020, v. 93, n. 2, p. 73, doi. 10.1159/000508291
- By:
- Publication type:
- Article
Prenatal Diagnosis of Cystic Fibrosis by Celocentesis.
- Published in:
- Genes, 2024, v. 15, n. 6, p. 662, doi. 10.3390/genes15060662
- By:
- Publication type:
- Article
Lung Inflammatory Genes in Cystic Fibrosis and Their Relevance to Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies.
- Published in:
- Genes, 2023, v. 14, n. 10, p. 1966, doi. 10.3390/genes14101966
- By:
- Publication type:
- Article
Evaluation of Liftover Tools for the Conversion of Genome Reference Consortium Human Build 37 to Build 38 Using ClinVar Variants.
- Published in:
- Genes, 2023, v. 14, n. 10, p. 1875, doi. 10.3390/genes14101875
- By:
- Publication type:
- Article
Quantitative Evaluation of CFTR Gene Expression: A Comparison between Relative Quantification by Real-Time PCR and Absolute Quantification by Droplet Digital PCR.
- Published in:
- Genes, 2023, v. 14, n. 9, p. 1781, doi. 10.3390/genes14091781
- By:
- Publication type:
- Article
Clinical and Genetic Characteristics of a Patient with Cystic Fibrosis with a Complex Allele [E217G;G509D] and Functional Evaluation of the CFTR Channel.
- Published in:
- Genes, 2023, v. 14, n. 9, p. 1705, doi. 10.3390/genes14091705
- By:
- Publication type:
- Article